United Therapeutics Europe Clinical Trials

Company details

Status: Public
HQ: 1000 Spring Street, Silver Spring, Maryland 20910, US
Founded: 1996
Employees: 1,443
Programs: 1032
Drugs: 612
Patents: 3720

Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

Medicare's GLP-1 Stance and UnitedHealthcare Lawsuit: Key Implications for Pharma Jun 2, 2026

View all news & analysis →

Recent trial activity

8 updates

Latest clinical program signals indexed for United Therapeutics Europe.

Trial registry

537 studies

2023-504904-26-00
RIN-PF-305

Phase 3 active small_molecule

Progressive Pulmonary Fibrosis

CTIS ↗
2023-509304-16-00
ROR-PH-301

Phase 3 active small_molecule

Pulmonary arterial hypertension (PAH)

CTIS ↗
2023-509305-68-00
ROR-PH-303

Phase 3 active small_molecule

Pulmonary arterial hypertension (PAH)

CTIS ↗
2024-514761-19-00
RIN-PF-303

Phase 3 active small_molecule

Idiopathic Pulmonary Fibrosis

CTIS ↗
NCT00002582
CMF regimen

Phase 3 active small_molecule

Breast Cancer

CT.gov ↗
NCT00002892
recombinant interferon alfa

Phase 3 completed mab

Melanoma (Skin)

CT.gov ↗
NCT00003423
asparaginase

Phase 3 active small_molecule

Lymphoma

CT.gov ↗
NCT00004497
UT-15

Phase 3 completed small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT00004635
Thalidomide

Phase 3 completed small_molecule

Prostate Cancer

CT.gov ↗
NCT00005586
L-leucovorin

Phase 3 completed small_molecule

Colorectal Cancer

CT.gov ↗
NCT00007735
Doxycycline (200mg/day) or Placebo

Phase 3 completed small_molecule

Persian Gulf Syndrome

CT.gov ↗
NCT00022191
cisplatin

Phase 3 completed small_molecule

Bladder Cancer

CT.gov ↗
NCT00028756
doxorubicin hydrochloride

Phase 3 completed small_molecule

Stage III Bladder Cancer

CT.gov ↗
NCT00033683
CMF regimen

Phase 3 active small_molecule

Breast Cancer

CT.gov ↗
NCT00052455
lomustine

Phase 3 completed small_molecule

Brain and Central Nervous System Tumors

CT.gov ↗
NCT00060996
Remodulin® (treprostinil sodium) Injection

Phase 3 terminated small_molecule

Critical Limb Ischemia

CT.gov ↗
NCT00067041
Remodulin (treprostinil sodium) Injection

Phase 3 terminated small_molecule

Peripheral Vascular Disease

CT.gov ↗
NCT00077168
Anastrozole

Phase 3 active small_molecule

Breast Cancer

CT.gov ↗
NCT00109551
zinc sulphate dietary supplement

Phase 3 completed small_molecule

Nutrition

CT.gov ↗
NCT00115271
Nutritional supplements

Phase 3 completed small_molecule

Low Birth Weight

CT.gov ↗
NCT00122369
Self-hypnotic Relaxation

Phase 2 completed other

Breast Cancer

CT.gov ↗
NCT00123968
VRC-HIVDNA016-00-VP

Phase 2 completed mab

HIV Infections

CT.gov ↗
NCT00124826
Insulin

Phase 2 completed small_molecule

Acute Stroke

CT.gov ↗
NCT00128557
H.22.03.01.09.A2

Phase 3 completed other

Mortality Through Six Months of Age

CT.gov ↗
NCT00129532
1.0% C31G SAVVY vaginal gel

Phase 3 active small_molecule

HIV Infections

CT.gov ↗
NCT00130078
1.0% C31G SAVVY vaginal gel

Phase 3 active small_molecule

HIV Infections

CT.gov ↗
NCT00136370
Chlorhexidine

Phase 3 active small_molecule

Infant, Newborn, Diseases

CT.gov ↗
NCT00138918
OGX-011

Phase 2 completed mab

Prostate Cancer

CT.gov ↗
NCT00140582
Rituximab

Phase 3 completed small_molecule

Follicular Lymphoma

CT.gov ↗
NCT00147199
Inhaled treprostinil

Phase 3 active small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT00153777
Cellulose Sulfate gel (6%)

Phase 3 terminated small_molecule

HIV Infection

CT.gov ↗
NCT00158548
ITDCVC98

Phase 3 completed small_molecule

Malaria

CT.gov ↗
NCT00165204
Tibolone

Phase 2 completed small_molecule

Menopause

CT.gov ↗
NCT00198718
Vitamin A (retinyl palmitate)

Phase 2 completed small_molecule

Vitamin A Deficiency

CT.gov ↗
NCT00206453
Taxotere

Phase 2 terminated small_molecule

Breast Cancer

CT.gov ↗
NCT00213018
Carraguard (PC-515)

Phase 3 completed small_molecule

HIV Infections

CT.gov ↗
NCT00213083
Carraguard (PC-515)

Phase 3 completed small_molecule

HIV Infections

CT.gov ↗
NCT00213096
Population Council #323

Phase 2 completed small_molecule

Contraception

CT.gov ↗
NCT00223080
ALVAC-HIV vCP1521 + AIDSVAX

Phase 3 completed mab

HIV Infection

CT.gov ↗
NCT00238667
CAMER5UA

Phase 3 completed small_molecule

Cervical Artery Dissection

CT.gov ↗
NCT00243243
Recombinant Factor VIIa

Phase 3 completed small_molecule

Burns

CT.gov ↗
NCT00253422
Anastrozole

Phase 3 active small_molecule

Breast Cancer

CT.gov ↗
NCT00256724
Impedance Threshold Device

Phase 2 completed other

Hypotension

CT.gov ↗
NCT00262106
PRO 2000/5

Phase 3 completed small_molecule

HIV Infections

CT.gov ↗
NCT00285298
Pentoxifylline

Phase 3 completed small_molecule

Kidney Failure, Chronic

CT.gov ↗
NCT00299286
Lapatinib

Phase 2 completed small_molecule

Breast Cancer

CT.gov ↗
NCT00301925
pegfilgrastim

Phase 3 active mab

Breast Cancer

CT.gov ↗
NCT00310791
Hormone replacement therapy (estrogen/progestin)

Phase 3 completed small_molecule

Anorexia Nervosa

CT.gov ↗
NCT00325403
Oral treprostinil (UT-15C) sustained release tablets

Phase 3 completed small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT00325442
Oral treprostinil (UT-15C) sustained release tablets

Phase 3 completed small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT00336245
Hormonal Contraception

Phase 3 completed small_molecule

Pregnancy

CT.gov ↗
NCT00351702
Isoniazid with Ethambutol

Phase 3 completed small_molecule

Human Immunodeficiency Virus

CT.gov ↗
NCT00355043
Zinc sulphate 20 mg

Phase 3 completed small_molecule

Bronchiolitis

CT.gov ↗
NCT00385047
Group A FMP2.1/AS01B

Phase 2 completed mab

Malaria

CT.gov ↗
NCT00396500
Albendazole (400 mg) and/or Vitamin a

Phase 3 completed small_molecule

Malnutrition

CT.gov ↗
NCT00396526
9999

Phase 3 completed small_molecule

Non-Severe Pneumonia

CT.gov ↗
NCT00397696
[123I] 5-IA

Phase 2 completed small_molecule

Parkinson Disease

CT.gov ↗
NCT00402896
ZD6474

Phase 2 completed small_molecule

Lung Cancer

CT.gov ↗
NCT00404170
B-CIT and SPECT imaging

Phase 2 completed small_molecule

Parkinson Disease

CT.gov ↗
NCT00405678
Exercise Training

Phase 2 completed other

Breast Cancer

CT.gov ↗
NCT00407394
Amoxycillin

Phase 3 completed small_molecule

Non-Severe Pneumonia With Wheeze

CT.gov ↗
NCT00410059
Erlotinib

Phase 2 completed small_molecule

Lung Cancer

CT.gov ↗
NCT00410189
ZD6474

Phase 2 completed small_molecule

Lung Cancer

CT.gov ↗
NCT00411671
Sorafenib

Phase 2 completed small_molecule

Lung Cancer

CT.gov ↗
NCT00429156
Home non-invasive ventilation

Phase 3 completed other

Hypercapnic Respiratory Failure

CT.gov ↗
NCT00441298
Tenofovir gel

Phase 2 completed small_molecule

HIV Infections

CT.gov ↗
NCT00514800
Intervention - a validated home BP monitor and support from the specialist nurse

Phase 3 completed other

Stroke

CT.gov ↗
NCT00527982
Celecoxib

Phase 2 terminated small_molecule

Head and Neck Cancer

CT.gov ↗
NCT00532727
Carboplatin

Phase 3 active small_molecule

Breast Cancer

CT.gov ↗
NCT00541164
Coenzyme Q10

Phase 2 completed small_molecule

Charcot Marie Tooth Disease

CT.gov ↗
NCT00563784
Erlotinib

Phase 2 completed small_molecule

Non-Small Cell Lung Cancer

CT.gov ↗
NCT00583024
ADENOVIRUS/PSA VACCINE

Phase 2 completed mab

Hormone Refractory Prostate Cancer

CT.gov ↗
NCT00614198
Gluten- and casein-free diet

Phase 2 completed other

Autism

CT.gov ↗
NCT00622401
Dendritic Cell/Tumor Fusion Vaccine

Phase 2 terminated mab

Breast Cancer

CT.gov ↗
NCT00623090
educational internet site on prostate cancer screening

Phase 3 completed other

Prostate Cancer

CT.gov ↗
NCT00633087
2-deoxyglucose

Phase 2 terminated small_molecule

Prostate Cancer

CT.gov ↗
NCT00640445
Expressive Writing

Phase 3 completed other

Posttraumatic Stress Disorder

CT.gov ↗
NCT00651742
S-1

Phase 2 completed small_molecule

Locally Advanced or Metastatic Pancreatic Cancer

CT.gov ↗
NCT00651833
S-1

Phase 2 completed small_molecule

Advanced Non-Small Cell Lung Cancer

CT.gov ↗
NCT00652561
S-1

Phase 2 completed small_molecule

Advanced Non-Small Cell Lung Cancer

CT.gov ↗
NCT00707785
Vitamin A

Phase 3 completed other

Sepsis

CT.gov ↗
NCT00713739
Alfuzosin

Phase 3 active small_molecule

Kidney Stones

CT.gov ↗
NCT00734474
LY2189265

Phase 3 completed small_molecule

Diabetes Mellitus, Type 2

CT.gov ↗
NCT00749203
Midazolam

Phase 2 completed small_molecule

Stress Disorders, Post-Traumatic

CT.gov ↗
NCT00760851
probiotic strain Bb-12

Phase 3 completed other

Infections, Respiratory

CT.gov ↗
NCT00818051
intensity-modulated radiation therapy

Phase 3 active other

Breast Cancer

CT.gov ↗
NCT00849667
Farletuzumab

Phase 3 terminated small_molecule

Ovarian Cancer

CT.gov ↗
NCT00859781
177Lu-J591

Phase 2 active small_molecule

Prostate Cancer

CT.gov ↗
NCT00860470
Iron (27 mg) - folic acid (600 ug)

Phase 3 completed other

Infant Mortality

CT.gov ↗
NCT00866099
Educational Dementia training

Phase 3 active other

Dementia

CT.gov ↗
NCT00867347
radiation therapy

Phase 3 completed other

Bladder Cancer

CT.gov ↗
NCT00870987
DNA vaccine prime

Phase 2 completed mab

Malaria

CT.gov ↗
NCT00887978
UT-15C SR

Phase 3 completed small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT00904423
Vitamin D

Phase 2 terminated small_molecule

Breast Cancer

CT.gov ↗
NCT00907972
Vitamin D3

Phase 2 completed other

Parkinson Disease

CT.gov ↗
NCT00960466
Distress Thermometer and Problems List

Phase 3 completed other

Cancer

CT.gov ↗
NCT00965588
UB-311

Phase 2 terminated mab

Alzheimer's Disease

CT.gov ↗
NCT00969722
MAb-3F8

Phase 2 terminated mab

Primary Refractory Neuroblastoma

CT.gov ↗
NCT00977873
Cholecalciferol

Phase 3 completed other

Chronic Obstructive Pulmonary Disease

CT.gov ↗
NCT00978315
Cholecalciferol

Phase 3 completed other

Asthma

CT.gov ↗
NCT01000129
Adaptive-Planning Organ Localisation (A-POLO) (Planning CT scan)

Phase 2 active other

Bladder Cancer

CT.gov ↗
NCT01027949
Oral Treprostinil

Phase 3 completed small_molecule

Pulmonary Arterial Hypertension

CT.gov ↗
NCT01045564
GSK influenza virus H5N1 vaccine 1557484A

Phase 2 terminated mab

Influenza

CT.gov ↗
NCT01067287
CT-011

Phase 2 completed small_molecule

Multiple Myeloma

CT.gov ↗
NCT01069874
Cholecalciferol (Vitamin D/Vigantol oil)

Phase 3 completed other

Respiratory Tract Infections

CT.gov ↗
NCT01078909
Eicosapentaenoic Acid and Docosahexaenoic Acid (EPA + DHA)

Phase 3 completed mab

Cardiovascular Disease

CT.gov ↗
NCT01086475
D-cycloserine

Phase 3 completed small_molecule

Autistic Disorder

CT.gov ↗
NCT01099423
gene expression analysis

Phase 3 active gene_therapy

Kidney Cancer

CT.gov ↗
NCT01101438
metformin hydrochloride

Phase 3 completed small_molecule

Breast Cancer

CT.gov ↗
NCT01104571
trastuzumab

Phase 3 active mab

Breast Cancer

CT.gov ↗
NCT01104870
UT-15C

Phase 2 completed small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT01112046
Endoscopic submucosal dissection

Phase 3 active other

Colorectal Neoplasms

CT.gov ↗
NCT01119326
Autologous Fat Transfer

Phase 2 completed other

Wound

CT.gov ↗
NCT01120028
Alemtuzumab

Phase 3 completed small_molecule

Kidney Transplantation

CT.gov ↗
NCT01126697
Coenzyme Q10 and Lisinopril

Phase 3 completed small_molecule

Duchenne Muscular Dystrophy

CT.gov ↗
NCT01155024
Traditional fabricated prosthetic socket

Phase 2 completed other

Amputation

CT.gov ↗
NCT01157897
VMP001

Phase 2 completed mab

Malaria

CT.gov ↗
NCT01165034
Breathlessness Support Service

Phase 3 active other

Breathless Patients With Any Established Underlying Medical Diagnosis

CT.gov ↗
NCT01166815
Zinc sulphate

Phase 3 completed other

Diarrhea

CT.gov ↗
NCT01175993
Elliptical exercise

Phase 2 completed other

Adult

CT.gov ↗
NCT01202383
Household-based water treatment with NADCC tablets

Phase 3 completed other

Diarrhoea

CT.gov ↗
NCT01216800
3-dimensional conformal radiation therapy

Phase 3 active other

Head and Neck Cancer

CT.gov ↗
NCT01216982
Lovaza, omega-3 fatty acid ethyl ester

Phase 2 active small_molecule

Mood Disorders

CT.gov ↗
NCT01233609
Valproic Acid

Phase 2 completed small_molecule

Retinitis Pigmentosa

CT.gov ↗
NCT01241253
Whole cooked beans with rice meals

Phase 2 completed other

Blood Glucose

CT.gov ↗
NCT01249391
Splinting

Phase 2 completed other

Hand Osteoarthritis

CT.gov ↗
NCT01253915
Nasal Carbon Dioxide

Phase 2 terminated small_molecule

Migraine

CT.gov ↗
NCT01260454
Qutenza (8% capsaicin)

Phase 2 completed small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT01265433
Galinpepimut-S + Montanide + GM-CSF

Phase 2 completed mab

Malignant Pleural Mesothelioma

CT.gov ↗
NCT01305811
Acupuncture

Phase 2 completed other

Persian Gulf Syndrome

CT.gov ↗
NCT01324999
Tadalafil

Phase 3 completed small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT01326481
TRC105

Phase 2 completed small_molecule

Metastatic Breast Cancer

CT.gov ↗
NCT01332968
Obinutuzumab

Phase 3 completed small_molecule

Non-Hodgkin's Lymphoma

CT.gov ↗
NCT01333488
Magnesium Sulfate

Phase 2 terminated small_molecule

Traumatic Brain Injury

CT.gov ↗
NCT01337401
Cediranib

Phase 2 active small_molecule

Alveolar Soft-part Sarcoma

CT.gov ↗
NCT01352637
DCS (D-Cycloserine ) + Prolonged Imaginal Exposure

Phase 3 completed small_molecule

Post Traumatic Stress Disorder

CT.gov ↗
NCT01353209
Letrozole

Phase 2 completed small_molecule

Lymphangioleiomyomatosis

CT.gov ↗
NCT01386294
Tenofovir gel

Phase 3 completed small_molecule

HIV Prevention

CT.gov ↗
NCT01393795
Qutenza

Phase 2 completed small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT01398072
Moxifloxacin

Phase 3 active small_molecule

Chronic Obstructive Pulmonary Disease (COPD).

CT.gov ↗
NCT01402817
Sutent®/Sunitinib

Phase 2 terminated small_molecule

Neurofibromatosis

CT.gov ↗
NCT01414582
Anodal tDCS

Phase 3 active other

Stroke

CT.gov ↗
NCT01422668
Khalas dates

Phase 3 completed other

Diabetes Mellitus

CT.gov ↗
NCT01426555
Zoledronic acid

Phase 3 terminated small_molecule

Osteoporosis

CT.gov ↗
NCT01427673
Bipap procedure

Phase 3 active other

Chronic Obstructive Pulmonary Disease

CT.gov ↗
NCT01439022
Exercise Programme

Phase 2 completed other

Parkinson's Disease

CT.gov ↗
NCT01458561
BioFoam Surgical Matrix

Phase 3 terminated other

Intraoperative Bleeding

CT.gov ↗
NCT01460693
Imatinib

Phase 3 completed small_molecule

Myeloid Leukemia, Chronic, Chronic Phase

CT.gov ↗
NCT01474057
DESTRESS-PC

Phase 2 completed other

Posttraumatic Stress Disorder (PTSD)

CT.gov ↗
NCT01477333
UT-15C SR

Phase 3 completed small_molecule

Pulmonary Arterial Hypertension

CT.gov ↗
NCT01484184
SPINALON (buspirone + levodopa + cardidopa)

Phase 2 completed small_molecule

Spinal Cord Injury

CT.gov ↗
NCT01494519
Surgery with an external ring fixator

Phase 3 completed other

Severe Open Fractures of the Tibia (Shin) Bone

CT.gov ↗
NCT01503918
Valaciclovir/Aciclovir

Phase 2 completed small_molecule

Critical Illness

CT.gov ↗
NCT01518491
NanoDOX Hydrogel

Phase 2 terminated small_molecule

Orthopedic Trauma Wounds

CT.gov ↗
NCT01522768
Afatinib and Paclitaxel

Phase 2 completed small_molecule

Esophageal Cancer

CT.gov ↗
NCT01523470
BIPAP Synchrony

Phase 3 completed other

Chronic Obstructive Pulmonary Disease

CT.gov ↗
NCT01538459
Dexamethasone

Phase 3 terminated small_molecule

Shoulder Pain

CT.gov ↗
NCT01541852
Losmapimod

Phase 2 completed small_molecule

Chronic Obstructive Pulmonary Disease

CT.gov ↗
NCT01543997
Mind-Body Bridging Program

Phase 2 completed other

Sleep Disturbance

CT.gov ↗
NCT01545232
1:1:1 Blood Transfusion Ratio

Phase 3 completed mab

Trauma

CT.gov ↗
NCT01549899
In-person Cognitive Behavioral Therapy of Insomnia

Phase 3 completed other

Insomnia

CT.gov ↗
NCT01557153
Amlodipine

Phase 3 active small_molecule

Depression

CT.gov ↗
NCT01560637
UT-15C (treprostinil diolamine)

Phase 3 completed small_molecule

Pulmonary Arterial Hypertension

CT.gov ↗
NCT01562379
Wheat Soy Blend (WSB++)

Phase 3 completed other

Stunting

CT.gov ↗
NCT01588405
UT-15C SR

Phase 3 completed small_molecule

Pulmonary Arterial Hypertension

CT.gov ↗
NCT01597518
Riluzole

Phase 3 terminated small_molecule

Spinal Cord Injury

CT.gov ↗
NCT01605903
Ibuprofen

Phase 2 completed small_molecule

Tonsillectomy

CT.gov ↗
NCT01611935
Vasopressin

Phase 2 completed small_molecule

Traumatic Shock

CT.gov ↗
NCT01616784
CSII (Insulin Pump) plus DAFNE

Phase 3 completed other

Type 1 Diabetes

CT.gov ↗
NCT01629537
Stellate Ganglion Block injection with ropivicane

Phase 2 completed other

Post Traumatic Stress Disorder (PTSD)

CT.gov ↗
NCT01645787
4-aminopyridine

Phase 3 completed small_molecule

Spinal Muscular Atrophy

CT.gov ↗
NCT01650389
MVA85A

Phase 2 completed mab

Tuberculosis

CT.gov ↗
NCT01659307
Aspirin 75mg

Phase 2 completed small_molecule

Acute Lung Injury

CT.gov ↗
NCT01662726
Irosustat

Phase 2 terminated small_molecule

Breast Neoplasms

CT.gov ↗
NCT01668043
Antibody UB-421

Phase 2 completed small_molecule

HIV-1 Infection in Adults

CT.gov ↗
NCT01672710
GW093066

Phase 2 completed small_molecule

Gulf War Illness

CT.gov ↗
NCT01673828
Allopregnanolone injection

Phase 2 completed small_molecule

Traumatic Brain Injury

CT.gov ↗
NCT01685190
Prostate alone IMRT

Phase 2 active other

Prostate Cancer

CT.gov ↗
NCT01693822
Axitinib

Phase 2 completed small_molecule

Clear-cell Metastatic Renal Cell Carcinoma

CT.gov ↗
NCT01726374
BEP(500)

Phase 3 completed small_molecule

Stage I Testicular Non-Seminomatous Germ Cell Tumor

CT.gov ↗
NCT01728753
Placebo

Phase 2 completed small_molecule

Influenza

CT.gov ↗
NCT01767194
Dinutuximab

Phase 2 completed mab

Ganglioneuroblastoma

CT.gov ↗
NCT01783106
Ciprofloxacin

Phase 2 completed small_molecule

Crohn's Disease

CT.gov ↗
NCT01802814
SR-A + Epratuzumab

Phase 3 completed small_molecule

Acute Lymphoblastic Leukemia (ALL)

CT.gov ↗
NCT01819662
Enhanced standard management

Phase 3 active other

Pacemaker Complication

CT.gov ↗
NCT01822093
Cytovir-ADV

Phase 2 completed mab

ADV Infection Post Allo-HSCT

CT.gov ↗
NCT01825031
Raltegravir

Phase 3 completed small_molecule

Human Immunodeficiency Virus

CT.gov ↗
NCT01847469
Zonisamide

Phase 2 completed small_molecule

Alcohol Dependence

CT.gov ↗
NCT01862003
AZD8931

Phase 2 completed small_molecule

Metastatic Colorectal Cancer

CT.gov ↗
NCT01867294
Doxycycline

Phase 2 completed small_molecule

Advanced Malignant Neoplasm

CT.gov ↗
NCT01884038
treprostinil sodium

Phase 3 terminated small_molecule

Liver Transplant

CT.gov ↗
NCT01902810
Propranolol

Phase 3 terminated small_molecule

Burn

CT.gov ↗
NCT01908205
Intranasal Oxytocin

Phase 2 completed small_molecule

Autism Spectrum Disorder

CT.gov ↗
NCT01910259
Amiloride

Phase 2 completed small_molecule

Secondary Progressive Multiple Sclerosis

CT.gov ↗
NCT01928849
Valproic Acid

Phase 2 completed small_molecule

Pain, Phantom

CT.gov ↗
NCT01934582
UT-15C SR

Phase 3 completed small_molecule

Pulmonary Arterial Hypertension

CT.gov ↗
NCT01943825
CYD Dengue Vaccine

Phase 2 completed mab

Dengue

CT.gov ↗
NCT01984931
Trimebutine Maleate (NEWBUTIN SR 300 mg Tab)

Phase 3 active small_molecule

Nausea

CT.gov ↗
NCT01993979
Chemotherapy

Phase 3 active small_molecule

Transitional Cell Carcinoma of Ureter

CT.gov ↗
NCT01995344
Cyclophosphamide

Phase 2 terminated small_molecule

Metastatic Melanoma

CT.gov ↗
NCT01996826
Avastin® (bevacizumab)

Phase 2 completed small_molecule

Corneal Neovascularization

CT.gov ↗
NCT02025179
Teriparatide

Phase 2 completed small_molecule

Spinal Cord Injury

CT.gov ↗
NCT02030990
Mitomycin-C

Phase 3 active small_molecule

Corneal Opacity

CT.gov ↗
NCT02037529
Eribulin Mesylate

Phase 3 on hold small_molecule

Breast Adenocarcinoma

CT.gov ↗
NCT02044198
FMP2.1/AS01B

Phase 2 completed mab

Plasmodium Falciparum Malaria

CT.gov ↗
NCT02057913
Vinflunine

Phase 2 completed small_molecule

Locally-advanced or Metastatic Penile Neoplasms

CT.gov ↗
NCT02070120
Mitomycin C

Phase 2 active small_molecule

Bladder Cancer

CT.gov ↗
NCT02095873
Glyoxalase 1 (Glo1) inducer

Phase 2 completed other

Glucose Intolerance

CT.gov ↗
NCT02116205
HTNV/PUUV DNA vaccine

Phase 2 completed mab

Hemorrhagic Fever With Renal Syndrome

CT.gov ↗
NCT02130323
Imiquimod

Phase 3 completed small_molecule

Cervical Intraepithelial Neoplasia

CT.gov ↗
NCT02151734
KALOMIN™ Tab.

Phase 3 completed small_molecule

Acute Bronchitis

CT.gov ↗
NCT02153541
Antipyrine-benzocaine otic solution

Phase 2 active small_molecule

Asthma

CT.gov ↗
NCT02158520
Bevacizumab

Phase 2 completed mab

Metastatic Melanoma

CT.gov ↗
NCT02187224
Progesterone

Phase 3 completed small_molecule

Alcohol Dependence

CT.gov ↗
NCT02212678
N-acetylcysteine capsule

Phase 2 completed small_molecule

Parkinson Disease

CT.gov ↗
NCT02216383
Carbetocin

Phase 3 completed small_molecule

Post Partum Haemorrhage

CT.gov ↗
NCT02234180
Regorafenib

Phase 2 terminated small_molecule

Adenocarcinoma of the Gastroesophageal Junction

CT.gov ↗
NCT02252640
VAC059

Phase 2 completed mab

Plasmodium Falciparum Malaria

CT.gov ↗
NCT02257294
Alteplase

Phase 2 completed small_molecule

Myocardial Infarction

CT.gov ↗
NCT02261883
IV Remodulin

Phase 2 terminated small_molecule

Persistent Pulmonary Hypertension of the Newborn

CT.gov ↗
NCT02265809
Aldesleukin

Phase 2 completed small_molecule

Type 1 Diabetes

CT.gov ↗
NCT02279160
APD811

Phase 2 completed small_molecule

Pulmonary Arterial Hypertension

CT.gov ↗
NCT02279745
Ralinepag

Phase 2 completed small_molecule

Pulmonary Arterial Hypertension

CT.gov ↗
NCT02286921
Testosterone cypionate

Phase 2 completed small_molecule

Castration Resistant Metastatic Prostate Cancer

CT.gov ↗
NCT02292758
Bevacizumab

Phase 2 completed mab

Colorectal Adenocarcinoma

CT.gov ↗
NCT02296801
Letrozole

Phase 2 completed small_molecule

Breast Cancer

CT.gov ↗
NCT02297412
Minocycline Hydrochloride

Phase 2 completed small_molecule

Acute Pain

CT.gov ↗
NCT02307916
FGF-2

Phase 2 completed small_molecule

Tympanic Membrane Perforation

CT.gov ↗
NCT02308982
Immunoglobulins, Intravenous (Privigen)

Phase 3 completed small_molecule

Encephalitis

CT.gov ↗
NCT02314988
Tranexamic Acid

Phase 3 active small_molecule

Spinal Injuries

CT.gov ↗
NCT02317640
Testosterone Gel applied by a pump

Phase 2 active small_molecule

Spinal Cord Injury

CT.gov ↗
NCT02338310
Aromatase Inhibitors

Phase 3 active small_molecule

Breast Cancer

CT.gov ↗
NCT02341079
Bupivacaine Liposome Injection

Phase 3 terminated small_molecule

Osteoarthritis

CT.gov ↗
NCT02351531
Extensively Hydrolyzed formula

Phase 3 completed other

Cow Milk Allergy

CT.gov ↗
NCT02367521
NA_00090926

Phase 3 completed other

TBI Depression

CT.gov ↗
NCT02368886
Clobetasol Propionate

Phase 2 completed small_molecule

Colon Adenocarcinoma

CT.gov ↗
NCT02369146
UB-421

Phase 3 active mab

HIV-1 Infection

CT.gov ↗
NCT02370095
Treprostinil Inhalation Solution

Phase 2 terminated small_molecule

Respiratory Distress Syndrome, Adult

CT.gov ↗
NCT02375204
paclitaxel

Phase 3 active small_molecule

Germ Cell Tumor

CT.gov ↗
NCT02376335
Rituximab

Phase 2 completed mab

Fatigue

CT.gov ↗
NCT02380027
MRI

Phase 3 completed other

Prostate Neoplasm

CT.gov ↗
NCT02390674
Ciclosporin

Phase 2 completed small_molecule

Myocardial Reperfusion Injury

CT.gov ↗
NCT02393690
Selumetinib

Phase 2 completed small_molecule

Metastatic Thyroid Gland Carcinoma

CT.gov ↗
NCT02409212
Aerobic exercise training

Phase 2 completed other

Prostate Cancer

CT.gov ↗
NCT02415309
2 mg Melatonin

Phase 3 completed small_molecule

Anxiety

CT.gov ↗
NCT02418702
0.2 mg/kg ketamine

Phase 3 terminated small_molecule

Depression

CT.gov ↗
NCT02425423
New thickened formula

Phase 3 completed other

Gastroesophageal Reflux

CT.gov ↗
NCT02429427
Celecoxib

Phase 3 completed small_molecule

Breast Cancer

CT.gov ↗
NCT02447549
WBRT

Phase 2 active other

Bladder Cancer

CT.gov ↗
NCT02506192
Modified-Release Prednisone

Phase 2 completed small_molecule

Chronic Inflammation

CT.gov ↗
NCT02517099
Beclometasone

Phase 2 completed small_molecule

Asthma

CT.gov ↗
NCT02525068
AZD5363

Phase 2 active small_molecule

Adenocarcinoma of the Prostate

CT.gov ↗
NCT02525432
Placebo Infusion

Phase 2 active mab

Brain Injuries, Traumatic

CT.gov ↗
NCT02533336
abamectin and fenpyroximate

Phase 3 terminated small_molecule

Malaria

CT.gov ↗
NCT02535949
Tranexamic Acid

Phase 2 completed small_molecule

Hemorrhage

CT.gov ↗
NCT02551809
UB-311

Phase 2 terminated mab

Alzheimer's Disease

CT.gov ↗
NCT02578394
Anakinra 100mg and Placebo Depo-Medrone

Phase 3 completed small_molecule

Gout

CT.gov ↗
NCT02585713
Apixaban

Phase 3 completed small_molecule

Cerebral Vein Thrombosis

CT.gov ↗
NCT02587351
Metoprolol succinate

Phase 3 terminated small_molecule

Pulmonary Disease, Chronic Obstructive

CT.gov ↗
NCT02603068
Oral treprostinil

Phase 3 terminated small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT02618278
Physiotherapy

Phase 3 completed other

Sciatica

CT.gov ↗
NCT02630316
Inhaled treprostinil

Phase 3 active small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT02633293
Inhaled treprostinil

Phase 3 active small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT02656017
Metformin

Phase 2 completed small_molecule

Polycystic Kidney, Autosomal Dominant

CT.gov ↗
NCT02656082
Etanercept

Phase 2 completed small_molecule

Lupus Erythematosus, Discoid

CT.gov ↗
NCT02663895
Oral treprostinil

Phase 2 completed small_molecule

Systemic Sclerosis

CT.gov ↗
NCT02676947
Tocilizumab

Phase 2 completed small_molecule

Pulmonary Arterial Hypertension

CT.gov ↗
NCT02679560
Liposomal Bupivacaine

Phase 2 terminated small_molecule

Femoral Fractures

CT.gov ↗
NCT02719860
Green tea

Phase 2 completed other

Lung Cancer Prevention

CT.gov ↗
NCT02725255
Albendazole

Phase 3 completed small_molecule

Helminthiasis

CT.gov ↗
NCT02733614
SRX246

Phase 2 terminated small_molecule

PTSD

CT.gov ↗
NCT02742532
Oxytocin

Phase 2 completed small_molecule

Alcohol Use Disorder

CT.gov ↗
NCT02749968
Liposomal bupivacaine

Phase 2 completed small_molecule

Blunt Chest Wall Trauma

CT.gov ↗
NCT02758717
Brentuximab Vedotin

Phase 2 active small_molecule

Ann Arbor Stage IB Hodgkin Lymphoma

CT.gov ↗
NCT02759783
SBRT

Phase 3 active other

Prostate Cancer

CT.gov ↗
NCT02831257
AZD2014

Phase 2 completed small_molecule

Neurofibromatosis 2

CT.gov ↗
NCT02832648
selenase (selenium)

Phase 3 completed other

Osteoporosis

CT.gov ↗
NCT02863809
Riboflavin

Phase 2 completed small_molecule

Keratolysis

CT.gov ↗
NCT02873195
Atezolizumab

Phase 2 completed small_molecule

Metastatic Colorectal Carcinoma

CT.gov ↗
NCT02911285
N-acetylcysteine

Phase 2 completed small_molecule

Posttraumatic Stress Disorder (PTSD)

CT.gov ↗
NCT02915237
Concord grape juice

Phase 2 completed other

Gulf War Illness

CT.gov ↗
NCT02920528
Ketamine

Phase 3 completed small_molecule

Chronic Pain

CT.gov ↗
NCT02927249
Aspirin

Phase 3 terminated small_molecule

Node Positive HER2 Negative Breast Cancer

CT.gov ↗
NCT02927496
Doxycycline

Phase 3 completed small_molecule

Lymphedema

CT.gov ↗
NCT02928432
Steroids switch

Phase 2 completed small_molecule

Prostate Cancer

CT.gov ↗
NCT02929121
Doxycycline

Phase 3 completed small_molecule

Lymphedema

CT.gov ↗
NCT02929134
Doxycycline

Phase 3 completed small_molecule

Lymphedema

CT.gov ↗
NCT02932566
Pirfenidone

Phase 2 completed small_molecule

Cardiac Failure

CT.gov ↗
NCT02949115
70 mL red beetroot juice

Phase 2 active other

Overweight

CT.gov ↗
NCT02949219
Pembrolizumab

Phase 2 active mab

Metastatic Small Intestinal Adenocarcinoma

CT.gov ↗
NCT02953860
Fulvestrant with Enzalutamide

Phase 2 completed small_molecule

Breast Cancer

CT.gov ↗
NCT02955082
Carboplatin

Phase 2 active small_molecule

Hormone Refractory Prostate Cancer

CT.gov ↗
NCT02961790
Oxybutynin Chloride

Phase 3 completed small_molecule

Breast Carcinoma

CT.gov ↗
NCT02973152
Thyroplasty

Phase 2 completed other

Vocal Cord Paralysis Unilateral

CT.gov ↗
NCT02973997
Lenvatinib

Phase 2 completed small_molecule

Columnar Cell Variant Thyroid Gland Papillary Carcinoma

CT.gov ↗
NCT02978014
ProSpare

Phase 2 active other

Cancer

CT.gov ↗
NCT02988401
Insulin

Phase 2 completed small_molecule

Multiple Sclerosis, Relapsing-Remitting

CT.gov ↗
NCT02999906
Oral Treprostinil

Phase 3 completed small_molecule

Pulmonary Arterial Hypertension

CT.gov ↗
NCT03012646
Inhaled treprostinil

Phase 3 active small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT03016468
Parenteral Remodulin (treprostinil) injection

Phase 2 terminated small_molecule

Pulmonary Arterial Hypertension

CT.gov ↗
NCT03037580
Oral treprostinil

Phase 3 terminated small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT03043313
Trastuzumab

Phase 2 completed small_molecule

Metastatic Colorectal Adenocarcinoma

CT.gov ↗
NCT03055234
Oral Treprostinil

Phase 3 terminated small_molecule

Pulmonary Hypertension Associated With Sickle Cell Disease

CT.gov ↗
NCT03078530
Placebo

Phase 3 active small_molecule

Gulf War Illness

CT.gov ↗
NCT03079999
Aspirin

Phase 2 active small_molecule

Vestibular Schwannoma

CT.gov ↗
NCT03080883
Apixaban

Phase 3 completed small_molecule

Cerebral Vein Thrombosis

CT.gov ↗
NCT03087773
Empagliflozin 10 mg

Phase 3 completed small_molecule

Acute Myocardial Infarction

CT.gov ↗
NCT03098030
Dinutuximab

Phase 3 completed mab

Small Cell Lung Cancer

CT.gov ↗
NCT03145961
Pembrolizumab

Phase 2 active small_molecule

Triple Negative Breast Cancer

CT.gov ↗
NCT03149211
UB-421

Phase 3 active mab

HIV-1 Infection

CT.gov ↗
NCT03150511
Tesamorelin 2 Milligrams (MG)

Phase 2 active small_molecule

Peripheral Nerve Injuries

CT.gov ↗
NCT03177187
AZD5069

Phase 2 terminated small_molecule

Metastatic Castration Resistant Prostate Cancer

CT.gov ↗
NCT03182634
Fulvestrant

Phase 2 active small_molecule

Advanced Breast Cancer

CT.gov ↗
NCT03197922
Glycerin Suppository

Phase 3 completed small_molecule

Encopresis

CT.gov ↗
NCT03225248
UI05MSP015CT

Phase 3 completed small_molecule

Functional Dyspepsia

CT.gov ↗
NCT03249207
IL-1Ra

Phase 3 active small_molecule

Subarachnoid Hemorrhage

CT.gov ↗
NCT03256981
TKI

Phase 3 active small_molecule

NSCLC

CT.gov ↗
NCT03276572
225Ac-J591

Phase 2 active small_molecule

Prostate Cancer

CT.gov ↗
NCT03286101
0.5% Ivermectin lotion

Phase 2 completed small_molecule

Pediculosis Capitis

CT.gov ↗
NCT03327662
Active CTC Assessment

Phase 3 terminated other

Adenocarcinoma of the Prostate

CT.gov ↗
NCT03337087
Fluorouracil

Phase 2 active small_molecule

Metastatic Biliary Tract Carcinoma

CT.gov ↗
NCT03339258
Doxazosin Mesylate, Extended Release

Phase 2 active small_molecule

Stress Disorders, Post-Traumatic

CT.gov ↗
NCT03366844
Pembrolizumab

Phase 2 active small_molecule

Breast Cancer

CT.gov ↗
NCT03367312
Hyperpolarized 129Xenon gas

Phase 2 completed small_molecule

Pulmonary Vascular Disease

CT.gov ↗
NCT03382548
Reducing Antibiotics treatment duration

Phase 3 completed small_molecule

Ventilator Associated Pneumonia

CT.gov ↗
NCT03384914
DC1 Vaccine

Phase 2 active mab

Breast Cancer Female

CT.gov ↗
NCT03386539
Everolimus

Phase 3 active small_molecule

Pediatric Heart Transplantation

CT.gov ↗
NCT03418857
Yogurt smoothie with BB-12

Phase 2 active small_molecule

Metabolic Syndrome

CT.gov ↗
NCT03431558
bLF (Bovine lactoferrin)

Phase 3 active other

Neonatal Sepsis

CT.gov ↗
NCT03433183
Selumetinib

Phase 2 completed small_molecule

Malignant Peripheral Nerve Sheath Tumors

CT.gov ↗
NCT03496623
Inhaled treprostinil solution

Phase 3 terminated small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT03506997
Pembrolizumab

Phase 2 active small_molecule

Castration-resistant Prostate Cancer

CT.gov ↗
NCT03531710
UB-311

Phase 2 terminated mab

Alzheimer's Disease

CT.gov ↗
NCT03552705
Tranexamic Acid

Phase 2 active small_molecule

Anterior Cruciate Ligament Reconstruction

CT.gov ↗
NCT03555188
Ondansetron

Phase 3 completed small_molecule

IBS - Irritable Bowel Syndrome

CT.gov ↗
NCT03582176
Lactose Placebo

Phase 3 completed small_molecule

Elbow Fracture

CT.gov ↗
NCT03595995
UB-621

Phase 2 active mab

Genital Herpes

CT.gov ↗
NCT03626688
Ralinepag

Phase 3 terminated small_molecule

PAH

CT.gov ↗
NCT03686813
Sildenafil Citrate

Phase 2 completed small_molecule

Edema, Pulmonary

CT.gov ↗
NCT03696121
Desmopressin Injection

Phase 2 completed small_molecule

Stroke, Acute

CT.gov ↗
NCT03729219
E. coli ETVAX

Phase 2 completed mab

Diarrhea

CT.gov ↗
NCT03737344
IL-1Ra Kineret®

Phase 2 completed small_molecule

Intracerebral Haemorrhage

CT.gov ↗
NCT03737669
Mirasol-treated Fresh Whole Blood

Phase 3 completed mab

Transfusion-Transmitted Infectious Disease

CT.gov ↗
NCT03740893
AZD6738

Phase 2 active small_molecule

Breast Neoplasm

CT.gov ↗
NCT03743376
UB-421(25 mg/kg) Q2W

Phase 2 completed mab

HIV-1 Infection

CT.gov ↗
NCT03794583
Inhaled treprostinil solution

Phase 3 terminated small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT03795272
Rucaparib

Phase 2 terminated small_molecule

Cervical Cancer

CT.gov ↗
NCT03804944
Pembrolizumab (200mg IV for 30 minutes

Phase 2 active small_molecule

Breast Cancer

CT.gov ↗
NCT03814317
Inhaled Treprostinil

Phase 2 completed small_molecule

Sarcoidosis

CT.gov ↗
NCT03818854
Human Mesenchymal Stromal Cells

Phase 2 completed mab

Respiratory Distress Syndrome, Adult

CT.gov ↗
NCT03829358
Lactobacillus plantarum IS-10506

Phase 3 completed small_molecule

Constipation - Functional

CT.gov ↗
NCT03837977
Liposomal Irinotecan

Phase 2 completed small_molecule

Oncology

CT.gov ↗
NCT03852628
2mg Buprenex and 380mg Vivitrol

Phase 2 terminated small_molecule

Post Traumatic Stress Disorder

CT.gov ↗
NCT03861390
60 mg Prednisone

Phase 2 completed small_molecule

Airway Inflammation

CT.gov ↗
NCT03885973
Lactobacillus plantarum

Phase 3 completed small_molecule

Constipation - Functional

CT.gov ↗
NCT03892746
Active tDCS + task oriented practice

Phase 2 completed other

Cervical Spinal Cord Injruy

CT.gov ↗
NCT03893032
Modafinil 200mg

Phase 2 active small_molecule

Cognition

CT.gov ↗
NCT03935828
Oral versus topical antibioitics

Phase 2 terminated small_molecule

Chronic Rhinosinusitis (Diagnosis)

CT.gov ↗
NCT03936517
Prednisolone

Phase 3 active small_molecule

Adrenal Insufficiency

CT.gov ↗
NCT03946202
Hydrogen Peroxide

Phase 2 active small_molecule

Breast Cancer

CT.gov ↗
NCT03947450
Autologous Skin Fibroblasts

Phase 2 active mab

Amputation

CT.gov ↗
NCT03979014
Gardasill 9™ vaccine

Phase 3 completed mab

Neoplasia

CT.gov ↗
NCT03981614
Binimetinib

Phase 2 completed small_molecule

Metastatic Colorectal Carcinoma

CT.gov ↗
NCT03992456
Panitumumab

Phase 2 active mab

Metastatic Colon Adenocarcinoma

CT.gov ↗
NCT03994783
Rituximab

Phase 3 terminated small_molecule

Kidney Transplant Rejection

CT.gov ↗
NCT03999437
TERBINAFINE HYDROCHLORIDE (1%)

Phase 2 active small_molecule

Tinea Pedis

CT.gov ↗
NCT04005469
Treprostinil

Phase 2 active small_molecule

Ischemia Reperfusion Injury

CT.gov ↗
NCT04041791
Benzyl penicillin

Phase 3 completed small_molecule

Pneumonia

CT.gov ↗
NCT04042831
Olaparib

Phase 2 active small_molecule

Bile Duct Adenocarcinoma

CT.gov ↗
NCT04051957
Isosorbide Mononitrate

Phase 2 terminated small_molecule

Kidney Injury

CT.gov ↗
NCT04060017
Levoleucovorin Calcium

Phase 2 active small_molecule

Autism Spectrum Disorder

CT.gov ↗
NCT04065269
Ceralasertib

Phase 2 active small_molecule

Gynaecological Cancers

CT.gov ↗
NCT04084678
Ralinepag

Phase 3 terminated small_molecule

PAH

CT.gov ↗
NCT04117945
Cetuximab

Phase 2 active mab

BRAF V600E Negative

CT.gov ↗
NCT04136548
Fentanyl

Phase 2 completed small_molecule

Healthy

CT.gov ↗
NCT04196855
Teriparatide

Phase 3 active small_molecule

Stress Fracture

CT.gov ↗
NCT04197687
Multi-epitope HER2 Peptide Vaccine TPIV100

Phase 2 active mab

Breast Adenocarcinoma

CT.gov ↗
NCT04205656
Leukocyte-Poor Platelet Rich Plasma (LP-PRP)

Phase 2 active mab

Osteoarthritis, Knee

CT.gov ↗
NCT04210986
Placebo oral capsule

Phase 2 completed small_molecule

Osteoarthritis, Knee

CT.gov ↗
NCT04212650
Losartan

Phase 2 terminated small_molecule

Hip Osteoarthritis

CT.gov ↗
NCT04220021
Metformin

Phase 2 active small_molecule

C9orf72 Amyotrophic Lateral Sclerosis (ALS)

CT.gov ↗
NCT04226248
Rivastigmine Transdermal System

Phase 3 completed small_molecule

Parkinson Disease

CT.gov ↗
NCT04302181
Ropivacaine injection

Phase 2 active small_molecule

Stress Disorders, Post-Traumatic

CT.gov ↗
NCT04312997
PUL-042 Inhalation Solution

Phase 2 completed small_molecule

COVID-19

CT.gov ↗
NCT04313023
PUL-042 Inhalation Solution

Phase 2 completed small_molecule

COVID-19

CT.gov ↗
NCT04343885
177Lu-PSMA-617

Phase 2 active small_molecule

Metastatic Hormone Naive Prostate Cancer

CT.gov ↗
NCT04349176
Dose

Phase 3 terminated small_molecule

Chronic Migraine, Headache

CT.gov ↗
NCT04353180
Drug Isotretinoin (13 cis retinoic acid ) capsules+standard treatment

Phase 3 active small_molecule

COVID19

CT.gov ↗
NCT04360681
Lofexidine

Phase 2 completed small_molecule

Post Traumatic Stress Disorder

CT.gov ↗
NCT04362189
HB-adMSC

Phase 2 terminated mab

COVID-19

CT.gov ↗
NCT04373460
SARS-CoV-2 convalescent plasma

Phase 2 completed mab

SARS-CoV 2

CT.gov ↗
NCT04387227
Carboplatin

Phase 2 active small_molecule

Recurrent Fallopian Tube Carcinoma

CT.gov ↗
NCT04390243
Binimetinib

Phase 2 terminated small_molecule

Locally Advanced Pancreatic Carcinoma

CT.gov ↗
NCT04395365
Co-Trimoxazole 960Mg Dispersible Tablet

Phase 3 active small_molecule

Spontaneous Bacterial Peritonitis

CT.gov ↗
NCT04406727
UB-421

Phase 3 active mab

HIV-1 Infection

CT.gov ↗
NCT04411680
Sargramostim

Phase 2 completed small_molecule

COVID-19

CT.gov ↗
NCT04416750
Imatinib Mesylate

Phase 2 active small_molecule

Pulmonary Arterial Hypertension

CT.gov ↗
NCT04453293
BCG (Tokyo 172) vaccine

Phase 3 terminated mab

Tuberculosis Infection

CT.gov ↗
NCT04456413
Convalescent Plasma

Phase 2 terminated mab

COVID-19

CT.gov ↗
NCT04458311
Abiraterone Acetate

Phase 2 terminated small_molecule

Metastatic Castration Resistant Prostate Cancer

CT.gov ↗
NCT04470544
Camostat Mesilate

Phase 2 completed small_molecule

Severe Acute Respiratory Syndrome

CT.gov ↗
NCT04481048
N-Acetyl cysteine

Phase 2 active small_molecule

Neurofibromatosis 1

CT.gov ↗
NCT04531579
Valproic Acid Solution

Phase 2 terminated small_molecule

Acute Kidney Injury

CT.gov ↗
NCT04533464
MultiStem

Phase 2 active mab

Trauma

CT.gov ↗
NCT04534959
Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)

Phase 3 active other

Critical Illness

CT.gov ↗
NCT04534972
Targeting Normoxemia (SpO2 90-96%; PaO2 60-100 mmHg)

Phase 3 active other

Critical Illness

CT.gov ↗
NCT04545749
UB-612

Phase 2 completed mab

COVID-19

CT.gov ↗
NCT04552223
Nivolumab

Phase 2 completed small_molecule

Metastatic Uveal Melanoma

CT.gov ↗
NCT04584853
Abemaciclib

Phase 3 active small_molecule

Breast Cancer Female

CT.gov ↗
NCT04587583
WeCareAdvisor

Phase 2 completed other

Dementia

CT.gov ↗
NCT04595019
SBRT

Phase 3 active other

Prostate Cancer

CT.gov ↗
NCT04595136
Drug COVID19-0001-USR

Phase 2 active small_molecule

SARS-CoV-2 Infection

CT.gov ↗
NCT04597008
Treatment group

Phase 3 completed small_molecule

Post Operative Surgical Site Infection

CT.gov ↗
NCT04626791
Acalabrutinib

Phase 2 active small_molecule

Mantle Cell Lymphoma

CT.gov ↗
NCT04632537
Tice® BCG (for intravesical use) BCG LIVE strain of the BCG (Merck) vaccine

Phase 3 terminated small_molecule

COVID-19

CT.gov ↗
NCT04660760
Paclitaxel

Phase 2 active small_molecule

Clinical Stage III Gastric Cancer AJCC v8

CT.gov ↗
NCT04665115
Ibrutinib

Phase 2 terminated small_molecule

Asymptomatic COVID-19 Infection Laboratory-Confirmed

CT.gov ↗
NCT04667468
Cold Stored Platelets (CSP)

Phase 2 completed mab

Trauma

CT.gov ↗
NCT04671017
VLA2001

Phase 2 completed mab

SARS-CoV-2 Virus Infection

CT.gov ↗
NCT04684121
Granexin® gel (200 μM)

Phase 2 terminated small_molecule

Second Degree Burn

CT.gov ↗
NCT04684719
low titer whole blood

Phase 3 completed mab

Hemorrhagic Shock

CT.gov ↗
NCT04695080
Cladribine (MAVENCLAD®)

Phase 3 active small_molecule

Advanced Multiple Sclerosis

CT.gov ↗
NCT04706429
Trientine

Phase 2 completed small_molecule

Hypertrophic Cardiomyopathy

CT.gov ↗
NCT04707664
Sargramostim

Phase 2 completed small_molecule

Covid19

CT.gov ↗
NCT04708782
Placebo

Phase 3 completed small_molecule

Idiopathic Pulmonary Fibrosis

CT.gov ↗
NCT04727437
Warfarin

Phase 3 active small_molecule

Subsegmental Pulmonary Embolism Nos

CT.gov ↗
NCT04762888
Gallium Ga 68 Gozetotide

Phase 2 completed small_molecule

Hepatocellular Carcinoma

CT.gov ↗
NCT04768569
Zonisamide 100Mg Cap

Phase 2 terminated small_molecule

Hearing Loss, Noise-Induced

CT.gov ↗
NCT04773067
UB-612

Phase 2 completed mab

COVID-19

CT.gov ↗
NCT04774250
Zonisamide 100Mg Cap

Phase 2 terminated small_molecule

Hearing Loss, Noise-Induced

CT.gov ↗
NCT04782947
Exoskeletal assisted walking

Phase 3 active other

Spinal Cord Injuries

CT.gov ↗
NCT04789044
NTX-001

Phase 2 active small_molecule

Peripheral Nerve Injuries

CT.gov ↗
NCT04794348
Fresh Frozen Plasma (FFP)

Phase 2 terminated mab

Anticoagulant Reversal

CT.gov ↗
NCT04797286
Sildenafil

Phase 2 active small_molecule

Scleroderma

CT.gov ↗
NCT04802590
Ibrutinib 560 mg

Phase 2 active small_molecule

Mantle Cell Lymphoma

CT.gov ↗
NCT04834414
Cold Stored Platelets

Phase 3 completed mab

Acute Blood Loss

CT.gov ↗
NCT04839497
Autologous Volar Fibroblast Injection into the Terminal Limb of Amputees

Phase 2 active other

Amputation

CT.gov ↗
NCT04870333
Niclosamide

Phase 3 completed small_molecule

Covid19

CT.gov ↗
NCT04879368
Regorafenib

Phase 3 active small_molecule

Gastro-Oesophageal Cancer

CT.gov ↗
NCT04905693
Inhaled Treprostinil

Phase 3 active small_molecule

Idiopathic Pulmonary Fibrosis

CT.gov ↗
NCT04941911
Octreotide Acetate

Phase 2 active small_molecule

Liver Transplantation

CT.gov ↗
NCT04946370
225Ac-J591

Phase 2 active small_molecule

Prostate Cancer

CT.gov ↗
NCT04957485
Tecovirimat

Phase 2 active small_molecule

Smallpox

CT.gov ↗
NCT04964947
Tobramycin Injection

Phase 3 active small_molecule

Wound Infection

CT.gov ↗
NCT04967742
UB-612

Phase 2 completed mab

COVID-19

CT.gov ↗
NCT04971109
TPOXX

Phase 3 completed small_molecule

Smallpox

CT.gov ↗
NCT04985266
Palbociclib 125Mg Tab

Phase 2 active small_molecule

ER+ Breast Cancer

CT.gov ↗
NCT05025956
Fisetin

Phase 2 active small_molecule

Femoroacetabular Impingement

CT.gov ↗
NCT05056974
UB-421

Phase 3 active mab

HIV-1 Infection

CT.gov ↗
NCT05077332
Famotidine

Phase 2 terminated small_molecule

2019 Novel Coronavirus Disease

CT.gov ↗
NCT05077969
Famotidine

Phase 2 terminated small_molecule

2019 Novel Coronavirus Disease

CT.gov ↗
NCT05085028
Pembrolizumab 25 MG/ML [Keytruda]

Phase 3 active small_molecule

Lung Cancer, Nonsmall Cell

CT.gov ↗
NCT05085574
Famotidine

Phase 2 terminated small_molecule

2019 Novel Coronavirus Disease

CT.gov ↗
NCT05093231
Pembrolizumab

Phase 2 active small_molecule

Pancreatic Cancer

CT.gov ↗
NCT05101564
Alpelisib

Phase 2 completed small_molecule

Breast Cancer

CT.gov ↗
NCT05111028
Autologous Room Temperature stored Platelet transfusion

Phase 2 active mab

Reversal of Platelet Aggregation Inhibitors

CT.gov ↗
NCT05122559
N-acetyl cysteine

Phase 2 active small_molecule

Multiple Sclerosis

CT.gov ↗
NCT05151055
Lactezin

Phase 2 active other

Hormonal Acne

CT.gov ↗
NCT05160441
Platelet Rich Plasma Injection

Phase 3 completed mab

Osteoarthritis of the Shoulder

CT.gov ↗
NCT05167253
UB-612

Phase 2 completed mab

COVID-19

CT.gov ↗
NCT05168163
Atezolizumab

Phase 2 active mab

Locally Advanced Hepatocellular Carcinoma

CT.gov ↗
NCT05190094
Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole)

Phase 2 active small_molecule

Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer

CT.gov ↗
NCT05194293
Durvalumab

Phase 2 active mab

Stage IB Hepatocellular Carcinoma AJCC v8

CT.gov ↗
NCT05199285
Ipilimumab

Phase 2 terminated mab

BCLC Stage B Hepatocellular Carcinoma

CT.gov ↗
NCT05220787
Cold stored platelets in 100% plasma stored for 10-14 days

Phase 2 active mab

Hemorrhage

CT.gov ↗
NCT05231122
Anti-CD40 Agonist Monoclonal Antibody CDX-1140

Phase 2 active mab

Ovarian Clear Cell Adenocarcinoma

CT.gov ↗
NCT05246670
Palmidrol

Phase 2 active small_molecule

Chemotherapy-Induced Peripheral Neuropathy

CT.gov ↗
NCT05259904
L-citrulline

Phase 2 active small_molecule

Post Deployment Related Asthma

CT.gov ↗
NCT05268796
Behavior therapy

Phase 3 active other

Autism Spectrum Disorder

CT.gov ↗
NCT05288348
Sufentanil 30 MCG Sublingual Tablet

Phase 3 completed small_molecule

Traumatic Injury

CT.gov ↗
NCT05298215
UB-221

Phase 2 active mab

Chronic Spontaneous Urticaria

CT.gov ↗
NCT05348993
G03-52-01

Phase 2 completed small_molecule

Healthy

CT.gov ↗
NCT05355272
Recombinant human growth hormone

Phase 2 active small_molecule

Gulf War Syndrome

CT.gov ↗
NCT05356897
Trastuzumab

Phase 2 terminated mab

Metastatic Colon Adenocarcinoma

CT.gov ↗
NCT05371496
Semaglutide

Phase 2 active small_molecule

Cardiomyopathy

CT.gov ↗
NCT05405868
Nicotinomide

Phase 3 active small_molecule

Glaucoma, Open-Angle

CT.gov ↗
NCT05437575
Ketamine Hydrochloride

Phase 3 active small_molecule

Traumatic Injury

CT.gov ↗
NCT05464082
Functional Precision Oncology

Phase 2 active other

Breast Cancer Recurrent

CT.gov ↗
NCT05516849
Oxandrolone

Phase 3 terminated small_molecule

Trauma Injury

CT.gov ↗
NCT05581121
Standard treatment: Control arm

Phase 3 active other

Cervical Carcinoma

CT.gov ↗
NCT05602142
[11C]CPPC PET ligand

Phase 2 active small_molecule

ALS

CT.gov ↗
NCT05613023
SBRT

Phase 3 active other

Prostate Cancer

CT.gov ↗
NCT05651594
Fluorouracil

Phase 2 active small_molecule

Clinical Stage II Esophageal Adenocarcinoma AJCC v8

CT.gov ↗
NCT05684692
Siltuximab

Phase 2 active small_molecule

Schwannomatosis

CT.gov ↗
NCT05699174
Standard of Care PO (oral) antibiotics

Phase 3 active small_molecule

Infections

CT.gov ↗
NCT05705024
Mesenchymal Stromal Cells

Phase 2 active mab

Corneal Ulcer

CT.gov ↗
NCT05732883
Dexamethasone

Phase 2 active small_molecule

Voice Change

CT.gov ↗
NCT05751720
GIP/GLP-1a

Phase 2 active small_molecule

Non-Alcoholic Fatty Liver Disease

CT.gov ↗
NCT05754073
1. Intranasal oxytocin spray

Phase 2 active small_molecule

Autism Spectrum Disorder

CT.gov ↗
NCT05796765
Micronized DHACM 40 mg

Phase 2 terminated mab

Knee Osteoarthritis

CT.gov ↗
NCT05826912
Atorvastatin Calcium

Phase 2 active small_molecule

Traumatic Brain Injury

CT.gov ↗
NCT05889741
Ropivacaine injection

Phase 2 active small_molecule

Stress Disorders, Post-Traumatic

CT.gov ↗
NCT05910801
Lenalidomide

Phase 2 active small_molecule

Recurrent Mantle Cell Lymphoma

CT.gov ↗
NCT05958342
Calcium Gluconate

Phase 2 active small_molecule

Trauma

CT.gov ↗
NCT05994742
Rifampicin

Phase 3 active small_molecule

Severe Acute Malnutrition

CT.gov ↗
NCT06040268
Advair HFA

Phase 2 active small_molecule

Altitude Edema

CT.gov ↗
NCT06073886
Active cTBS

Phase 2 active other

Post-Concussion Syndrome

CT.gov ↗
NCT06090227
Metformin + Standard of Care

Phase 2 active small_molecule

Focal Segmental Glomerulosclerosis

CT.gov ↗
NCT06126731
Enzalutamide 40mg

Phase 2 active small_molecule

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

CT.gov ↗
NCT06160206
Bevacizumab

Phase 2 active mab

Recurrent Glioblastoma

CT.gov ↗
NCT06238648
Epcoritamab

Phase 2 active mab

Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

CT.gov ↗
NCT06282965
Angiotensin (1-7)

Phase 2 active small_molecule

Traumatic Brain Injury

CT.gov ↗
NCT06293300
BoNT A

Phase 2 active small_molecule

Traumatic Brain Injury

CT.gov ↗
NCT06322953
Direct-Acting Oral Anticoagulants (used as per local standard practice)

Phase 3 active small_molecule

Traumatic Intracranial Haemorrhage

CT.gov ↗
NCT06411067
Erenumab

Phase 3 terminated small_molecule

Fibromyalgia

CT.gov ↗
NCT06458036
Selpercatinib Monotherapy

Phase 2 active small_molecule

Differentiated Thyroid Cancer

CT.gov ↗
NCT06528990
Telehealth Intervention

Phase 2 active other

Colorectal Cancer

CT.gov ↗
NCT06616597
Abiraterone acetate

Phase 2 active small_molecule

Prostate Cancer (Adenocarcinoma)

CT.gov ↗
NCT06630260
Avutometinib

Phase 2 active small_molecule

Glioblastoma Multiforme (GBM)

CT.gov ↗
NCT06644183
Roginolisib

Phase 2 active small_molecule

Leukemia

CT.gov ↗
NCT06652438
Revumenib

Phase 3 active small_molecule

Acute Myeloid Leukemia, Adult

CT.gov ↗
NCT06866262
Ipilimumab

Phase 2 active mab

Locally Advanced Clear Cell Renal Cell Carcinoma

CT.gov ↗
NCT06878560
10 GE Xenokidney

Phase 2 active mab

ESRD (End-Stage Renal Disease)

CT.gov ↗
NCT06961084
Iodine-124

Phase 2 active small_molecule

Thyroid Cancer

CT.gov ↗
NCT06967987
Bemarituzumab + Flot regimen

Phase 2 terminated small_molecule

Gastric and Gastro-oesophageal Junction (GEJ) Adenocarcinomas

CT.gov ↗
NCT06989866
Bupivacaine

Phase 3 active small_molecule

Postoperative Pain

CT.gov ↗
NCT07002320
SX-682

Phase 2 active small_molecule

Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

CT.gov ↗
NCT07006675
600 mg Ibuprofen

Phase 3 active small_molecule

Tibial Fractures

CT.gov ↗
NCT07023484
Carboplatin plus Paclitaxel

Phase 2 active small_molecule

Ovarian Cancer

CT.gov ↗
NCT07037836
Inhaled Treprostinil (Tyvaso Nebulizer)

Phase 2 active small_molecule

COPD (Chronic Obstructive Pulmonary Disease)

CT.gov ↗
NCT07071935
Non-invasive ventilation

Phase 2 active other

Amyotrophic Lateral Sclerosis (ALS)

CT.gov ↗
NCT07075016
Venetoclax 400

Phase 3 active small_molecule

Acute Myeloid Leukemia

CT.gov ↗
NCT07104630
Pulmonary Rehabilitation (PR)

Phase 2 active other

Non-small Cell Lung Cancer Stage III

CT.gov ↗
NCT07116681
Inhaled treprostinil

Phase 3 active small_molecule

Pulmonary Hypertension

CT.gov ↗
NCT07134335
UBT251

Phase 2 active small_molecule

Obesity &Amp; Overweight

CT.gov ↗
NCT07145151
UBT251

Phase 2 active small_molecule

Metabolic Dysfunction-associated Steatohepatitis (MASH)

CT.gov ↗
NCT07163624
UBT251 Injection 2.0 mg and UBT251 Injection Placebo

Phase 2 completed small_molecule

Type 2 Diabetes Mellitus (T2DM)

CT.gov ↗
NCT07177469
UBT251 Injection 2.0 mg and UBT251 Injection Placebo

Phase 2 completed small_molecule

Obesity &Amp; Overweight

CT.gov ↗
NCT07186192
Educational Intervention

Phase 3 active other

Hematologic Malignancies

CT.gov ↗
NCT07187011
PT150

Phase 2 active small_molecule

PTSD - Post Traumatic Stress Disorder

CT.gov ↗
NCT07221942
Enfortumab vedotin

Phase 2 active small_molecule

Metastatic Urothelial Carcinoma

CT.gov ↗
NCT07224763
GGTA1 KO Thymokidney

Phase 2 active mab

ESRD (End-Stage Renal Disease)

CT.gov ↗
NCT07251491
Psilocybin (Usona Institute)

Phase 2 active small_molecule

Spinal Cord Injury

CT.gov ↗
NCT07261241
Radiation: 131I-MIBG

Phase 2 active small_molecule

Neuroblastoma

CT.gov ↗
NCT07288151
3,4-Methylenedioxymethamphetamine (MDMA)

Phase 2 active small_molecule

Post Traumatic Stress Disorder

CT.gov ↗
NCT07520110
Metformin

Phase 3 active small_molecule

Idiopathic Pulmonary Fibrosis

CT.gov ↗
NCT07600385
UI022 or UI023 and co-administration of matching placebo

Phase 3 completed small_molecule

Peripheral Arterial Disease

CT.gov ↗